ArticleInternal medicine (Tokyo, Japan)2025

Severe Hypocalcemia During JAK1/2 Inhibitor Therapy for Myelofibrosis in a Patient with Liver Cirrhosis.

Mayuna Kurumazaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.